최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
DataON 바로가기다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
Edison 바로가기다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
Kafe 바로가기국가/구분 | United States(US) Patent 등록 |
---|---|
국제특허분류(IPC7판) |
|
출원번호 | US-0111800 (2015-01-14) |
등록번호 | US-10144933 (2018-12-04) |
우선권정보 | JP-2014-005509 (2014-01-15) |
국제출원번호 | PCT/JP2015/050716 (2015-01-14) |
국제공개번호 | WO2015/108047 (2015-07-23) |
발명자 / 주소 |
|
출원인 / 주소 |
|
대리인 / 주소 |
|
인용정보 | 피인용 횟수 : 0 인용 특허 : 339 |
Problem The purpose of the present invention is to provide: a chiral nucleic acid adjuvant having immunity-inducing activity and an immunity-inducing activator. Solution The present invention relates to an adjuvant which comprises oligonucleotides which comprise two to four sequences each represente
Problem The purpose of the present invention is to provide: a chiral nucleic acid adjuvant having immunity-inducing activity and an immunity-inducing activator. Solution The present invention relates to an adjuvant which comprises oligonucleotides which comprise two to four sequences each represented by 5′-X1CpG X2-3′ and has a length of 14 to 32 nucleotides, wherein a nucleic acid at 3′ end side of at least two CpG motifs is connected by phosphorothioate linkage, wherein each nucleic acids at 3′ end and 5′ end of the oligonucleotide is S type nucleic acids connected by phosphorothioate linkage, and wherein the oligonucleotide comprises at least one nucleic acid without phosphorothioate modification. The present invention relates to an immunity-inducible activator comprising the adjuvant.
1. A method for inducing an immune response, comprising administering to a subject an adjuvant, wherein the adjuvant comprises an oligonucleotide which comprises two to four CpG motifs each represented by 5′-X1CpGX2-3′ and has a length of 14 to 32 nucleotides;wherein each CpG is a non-methylated CpG
1. A method for inducing an immune response, comprising administering to a subject an adjuvant, wherein the adjuvant comprises an oligonucleotide which comprises two to four CpG motifs each represented by 5′-X1CpGX2-3′ and has a length of 14 to 32 nucleotides;wherein each CpG is a non-methylated CpG without a modified phosphate backbone;wherein the X1 is A;wherein the X2 is T;wherein the 3′ end side of at least two CpG motifs is independently connected to a nucleic acid moiety comprising a phosphorothioate linkage;wherein linkages at both the 5′ end and the 3′ end of the oligonucleotide are S type phosphorothioate linkages;wherein the oligonucleotide comprises at least one linkage that is not a phosphorothioate linkage outside of the CpG motif; andwherein the oligonucleotide comprises a 5′-ACpGTTSPTSP-3′ motif, wherein each SP represents an S type phosphorothioate linkage.
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.